» Articles » PMID: 38783347

Clinical Outcomes of Single Blastocyst Transfer with Machine Learning Guided Noninvasive Chromosome Screening Grading System in Infertile Patients

Overview
Publisher Biomed Central
Date 2024 May 23
PMID 38783347
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Prospective observational studies have demonstrated that the machine learning (ML) -guided noninvasive chromosome screening (NICS) grading system, which we called the noninvasive chromosome screening-artificial intelligence (NICS-AI) grading system, can be used embryo selection. The current prospective interventional clinical study was conducted to investigate whether this NICS-AI grading system can be used as a powerful tool for embryo selection.

Methods: Patients who visited our centre between October 2018 and December 2021 were recruited. Grade A and B embryos with a high probability of euploidy were transferred in the NICS group. The patients in the control group selected the embryos according to the traditional morphological grading. Finally, 90 patients in the NICS group and 161 patients in the control group were compared statistically for their clinical outcomes.

Results: In the NICS group, the clinical pregnancy rate (70.0% vs. 54.0%, p < 0.001), the ongoing pregnancy rate (58.9% vs. 44.7%, p = 0.001), and the live birth rate (56.7% vs. 42.9%, p = 0.001) were significantly higher than those of the control group. When the female was ≥ 35 years old, the clinical pregnancy rate (67.7% vs. 32.1%, p < 0.001), ongoing pregnancy rate (56.5% vs. 25.0%, p = 0.001), and live birth rate (54.8% vs. 25.0%, p = 0.001) in the NICS group were significantly higher than those of the control group. Regardless of whether the patients had a previous record of early spontaneous abortion or not, the live birth rate of the NICS group was higher than that of the control group (61.0% vs. 46.9%; 57.9% vs. 34.8%; 33.3% vs. 0%) but the differences were not statistically significant.

Conclusions: NICS-AI was able to improve embryo utilisation rate, and the live birth rate, especially for those ≥ 35 years old, with transfer of Grade A embryos being preferred, followed by Grade B embryos. NICS-AI can be used as an effective tool for embryo selection in the future.

Citing Articles

Artificial Intelligence and Machine Learning: An Updated Systematic Review of Their Role in Obstetrics and Midwifery.

Giaxi P, Vivilaki V, Sarella A, Harizopoulou V, Gourounti K Cureus. 2025; 17(3):e80394.

PMID: 40070886 PMC: 11895402. DOI: 10.7759/cureus.80394.


Artificial Intelligence in IVF Laboratories: Elevating Outcomes Through Precision and Efficiency.

Hew Y, Kutuk D, Duzcu T, Ergun Y, Basar M Biology (Basel). 2025; 13(12.

PMID: 39765654 PMC: 11727220. DOI: 10.3390/biology13120988.


Preimplantation development analysis of aneuploid embryos with different chromosomal abnormalities.

Si K, Ma B, Bai J, Wu L, He H, Jin L Heliyon. 2024; 10(23):e40686.

PMID: 39687119 PMC: 11647804. DOI: 10.1016/j.heliyon.2024.e40686.


A review of artificial intelligence applications in in vitro fertilization.

Zhang Q, Liang X, Chen Z J Assist Reprod Genet. 2024; 42(1):3-14.

PMID: 39400647 PMC: 11806189. DOI: 10.1007/s10815-024-03284-6.


Efficacy of non-invasive chromosome screening, preimplantation genetic testing for aneuploidy, and morphological grading in selecting embryos of patients with advanced maternal age: a three-armed prospective cohort study.

Sun Q, Xu J, Yao Y, Huang X, Zhao D, Lu S BMC Pregnancy Childbirth. 2024; 24(1):545.

PMID: 39152379 PMC: 11328393. DOI: 10.1186/s12884-024-06736-0.

References
1.
Xi H, Qiu L, Yao Y, Luo L, Sui L, Fu Y . Noninvasive Chromosome Screening for Evaluating the Clinical Outcomes of Patients With Recurrent Pregnancy Loss or Repeated Implantation Failure. Front Endocrinol (Lausanne). 2022; 13:896357. PMC: 9253989. DOI: 10.3389/fendo.2022.896357. View

2.
Chen L, Li W, Liu Y, Peng Z, Cai L, Zhang N . Non-invasive embryo selection strategy for clinical IVF to avoid wastage of potentially competent embryos. Reprod Biomed Online. 2022; 45(1):26-34. DOI: 10.1016/j.rbmo.2022.03.006. View

3.
Huang J, Yao Y, Jia J, Zhu X, Ma J, Wang J . Chromosome Screening of Human Preimplantation Embryos by Using Spent Culture Medium: Sample Collection and Chromosomal Ploidy Analysis. J Vis Exp. 2021; (175). DOI: 10.3791/62619. View

4.
Li X, Hao Y, Chen D, Ji D, Zhu W, Zhu X . Non-invasive preimplantation genetic testing for putative mosaic blastocysts: a pilot study. Hum Reprod. 2021; 36(7):2020-2034. DOI: 10.1093/humrep/deab080. View

5.
Yakovlev P, Vyatkina S, Polyakov A, Pavlova M, Volkomorov V, Yakovlev M . Neonatal and clinical outcomes after transfer of a mosaic embryo identified by preimplantation genetic testing for aneuploidies. Reprod Biomed Online. 2022; 45(1):88-100. DOI: 10.1016/j.rbmo.2022.01.010. View